Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy

被引：100

作者：

Song, Pan ^{[1
]}

Gao, Zirui ^{[2
]}

Bao, Yige ^{[1
]}

Chen, Li ^{[2
]}

Huang, Yuhe ^{[2
]}

Liu, Yanyan ^{[2
]}

Dong, Qiang ^{[1
]}

Wei, Xiawei ^{[2
]}

机构：

[1] Sichuan Univ, Inst Urol, Dept Urol, West China Hosp, Chengdu 610041, Sichuan, Peoples R China

[2] Sichuan Univ, Natl Clin Res Ctr Geriatr, Lab Aging Res & Canc Drug Target, State Key Lab Biotherapy,West China Hosp,Canc Ctr, 17 Block 3,Southern Renmin Rd, Chengdu 610041, Sichuan, Peoples R China

来源：

JOURNAL OF HEMATOLOGY & ONCOLOGY | 2024年 / 17卷 / 01期

基金：

美国国家科学基金会;

关键词：

SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; ELEMENT-BINDING PROTEIN; CELLS IN-VITRO; BETA-CATENIN; COLORECTAL-CANCER; STEM-CELLS; BREAST-CANCER; HEPATOCELLULAR CARCINOMAS; PROMOTER METHYLATION;

D O I：

10.1186/s13045-024-01563-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Wnt/beta-catenin signaling pathway plays a crucial role in various physiological processes, encompassing development, tissue homeostasis, and cell proliferation. Under normal physiological conditions, the Wnt/beta-catenin signaling pathway is meticulously regulated. However, aberrant activation of this pathway and downstream target genes can occur due to mutations in key components of the Wnt/beta-catenin pathway, epigenetic modifications, and crosstalk with other signaling pathways. Consequently, these dysregulations contribute significantly to tumor initiation and progression. Therapies targeting the Wnt/beta-catenin signaling transduction have exhibited promising prospects and potential for tumor treatment. An increasing number of medications targeting this pathway are continuously being developed and validated. This comprehensive review aims to summarize the latest advances in our understanding of the role played by the Wnt/beta-catenin signaling pathway in carcinogenesis and targeted therapy, providing valuable insights into acknowledging current opportunities and challenges associated with targeting this signaling pathway in cancer research and treatment.

引用

页数：30

共 353 条

[1] AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation [J].

Abitbol, Shirley ;

Dahmani, Rajae ;

Coulouarn, Cedric ;

Ragazzon, Bruno ;

Mlecnik, Bernhard ;

Senni, Nadia ;

Savall, Mathilde ;

Bossard, Pascale ;

Sohier, Pierre ;

Drouet, Valerie ;

Tournier, Emilie ;

Dumont, Florent ;

Sanson, Romain ;

Calderaro, Julien ;

Zucman-Rossi, Jessica ;

Vasseur-Cognet, Mireille ;

Just, Pierre-Alexandre ;

Terris, Benoit ;

Perret, Christine ;

Gilgenkrantz, Helene .

JOURNAL OF HEPATOLOGY, 2018, 68 (06) :1203-1213

[2] Enhanced targeting of CML stem and progenitor cells by inhibition of porcupine acyltransferase in combination with TKI [J].

Agarwal, Puneet ;

Zhang, Bin ;

Ho, Yinwei ;

Cook, Amy ;

Li, Ling ;

Mikhail, Fady M. ;

Wang, Youzhen ;

McLaughlin, Margaret E. ;

Bhatia, Ravi .

BLOOD, 2017, 129 (08) :1008-1020

[3] Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer [J].

Ai, Lingbao ;

Tao, Qian ;

Zhong, Sheng ;

Fields, C. Robert ;

Kim, Wan-Ju ;

Lee, Michael W. ;

Cui, Yan ;

Brown, Kevin D. ;

Robertson, Keith D. .

CARCINOGENESIS, 2006, 27 (07) :1341-1348

[4] Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer [J].

Aizawa, Takashi ;

Karasawa, Hideaki ;

Funayama, Ryo ;

Shirota, Matsuyuki ;

Suzuki, Takashi ;

Maeda, Shimpei ;

Suzuki, Hideyuki ;

Yamamura, Akihiro ;

Naitoh, Takeshi ;

Nakayama, Keiko ;

Unno, Michiaki .

CANCER MEDICINE, 2019, 8 (14) :6370-6382

[5] IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf [J].

Albanese, C ;

Wu, KM ;

D'Amico, M ;

Jarrett, C ;

Joyce, D ;

Hughes, J ;

Hulit, J ;

Sakamaki, T ;

Fu, MF ;

Ben-Ze'ev, A ;

Bromberg, JF ;

Lamberti, C ;

Verma, U ;

Gaynor, RB ;

Byers, SW ;

Pestell, RG .

MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (02) :585-599

[6] Wnt proteins synergize to activate β-catenin signaling [J].

Alok, Anshula ;

Lei, Zhengdeng ;

Jagannathan, N. Suhas ;

Kaur, Simran ;

Harmston, Nathan ;

Rozen, Steven G. ;

Tucker-Kellogg, Lisa ;

Virshup, David M. .

JOURNAL OF CELL SCIENCE, 2017, 130 (09) :1532-1544

[7] WNT signalling pathways as therapeutic targets in cancer [J].

Anastas, Jamie N. ;

Moon, Randall T. .

NATURE REVIEWS CANCER, 2013, 13 (01) :11-26

[8] The CREB-Binding Protein Inhibitor ICG-001 Suppresses Pancreatic Cancer Growth [J].

Arensman, Michael D. ;

Telesca, Donatello ;

Lay, Anna R. ;

Kershaw, Kathleen M. ;

Wu, Nanping ;

Donahue, Timothy R. ;

Dawson, David W. .

MOLECULAR CANCER THERAPEUTICS, 2014, 13 (10) :2303-2314

[9] In melanoma, beta-catenin is a suppressor of invasion [J].

Arozarena, I. ;

Bischof, H. ;

Gilby, D. ;

Belloni, B. ;

Dummer, R. ;

Wellbrock, C. .

ONCOGENE, 2011, 30 (45) :4531-4543

[10] Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer [J].

Arques, Oriol ;

Chicote, Irene ;

Puig, Isabel ;

Tenbaum, Stephan P. ;

Argiles, Guillem ;

Dienstmann, Rodrigo ;

Fernandez, Natalia ;

Caratu, Ginevra ;

Matito, Judit ;

Silberschmidt, Daniel ;

Rodon, Jordi ;

Landolfi, Stefania ;

Prat, Aleix ;

Espin, Eloy ;

Charco, Ramon ;

Nuciforo, Paolo ;

Vivancos, Ana ;

Shao, Wenlin ;

Tabernero, Josep ;

Palmer, Hector G. .

CLINICAL CANCER RESEARCH, 2016, 22 (03) :644-656

← 1 2 3 4 5 6 7 8 9 10 →